United States · 
Who invested in Solstice Biologics?
Solstice Biologics's investors include Aeris Capital and venBio Partners.
20132014
$3.0MGrowth$7.5MGrowth$7.5MSeries BUnited States · Series B startup
Who invested in Solstice Biologics
4 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$36Mraised across 4 rounds since 2012, from 4 sources
$3.0MGrowth$7.5MGrowth$18MSeries A$7.5MSeries B
- Latest round
- Series B, $7.5MOct 2014
- Biggest round
- $18MSeries A · Jan 2013
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Growth, $3.0M Dec 2012
- Biggest round
- $18M Series A · Jan 2013
- Between rounds
- 21 months from the last two
The rounds
- Oct 2014Series B$7.5M
No investor was named in the report.
From a historical funding recordSEC filing: $7.5M sold, first sale Sept 2014
- Jan 2013Series A$18M2 returning
Reported by finsmes.comSEC filing: $7.5M sold, first sale Dec 2012
- Dec 2012Growth$7.5M2 new
Reported by sec.govSEC filing: $7.5M sold, first sale Dec 2012
- Dec 2012Growth$3.0M
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Nov 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Aeris CapitalGrowth equity2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Solstice Biologics
How much has Solstice Biologics raised?
Solstice Biologics has raised $36M across 4 rounds since 2012.
When did Solstice Biologics last raise?
Solstice Biologics's most recent round was a Series B of $7.5M in Oct 2014.
What was Solstice Biologics's biggest round?
Solstice Biologics's largest round on record is $18M (Series A), in Jan 2013.
Who backed Solstice Biologics first?
Solstice Biologics's first round on record, in Dec 2012, was backed by Aeris Capital and venBio Partners.
What stage is Solstice Biologics at?
Solstice Biologics's latest named round is a Series B, in Oct 2014.
Where is Solstice Biologics based?
Solstice Biologics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.